Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 149 for “"soft tissue sarcoma"”.
-
Genetic Profiling in Soft Tissue Sarcoma
Soft tissue sarcomas (STS) are a heterogeneous group of highly malignant mesenchymal tumors that account for ~1% of all malignancies. Frequent heterogeneity and pleomorphism along with suboptimal diagnostic reproducibility and insufficient prognostic markers make clinical management of these tumors …
-
Soft tissue sarcoma: biology and therapeutic correlates
Soft tissue sarcomas (STS) comprise a heterogenenous group of greater than 50 malignancies of putative mesenchymal cell origin and as such they may arise in diverse tissue types in various anatomical locations throughout the whole body. Collectively they account for approximately 1% of all human …
-
Clinical and Biological Patterns in Soft Tissue Sarcoma
Soft tissue sarcomas (STSs) are rare malignant tumors, of which 3/4 are high-grade and 1/3 metastasize. For optimal management, STSs should be treated at multidisciplinary sarcoma centers. Study I demonstrated that simple referral guidelines, an open-access outpatient clinic and repeated educative …
-
Soft Tissue Sarcoma Patterns multiplicity, heterogeneity and growth characteristics
Soft tissue sarcomas (STS) represent a group of rare and heterogenous tumors that optimally should be diagnosed and treated within multidisciplinary teams. This thesis has studied various aspects ? pathological, genetical, and clinical ? of STS. In study I, we demonstrated that 20% of the patients …
-
Characterisation of stromal gene expression in soft tissue sarcoma
Background: Soft Tissue Sarcomas (STS) are a biologically rare, heterogeneous and complex population of solid tumours of mesenchymal origin. Recent studies have emphasised the important role of mesenchymal cells like fibroblasts in cancer biology. Very little is known about the role of Sarcoma …
-
ADDICTION OF SOFT-TISSUE SARCOMA CELLS TO MNK AND EIF4E
Soft-tissue sarcomas (STSs) are a group of rare diseases that arise from connective tissues. The overall clinical outcome of patients with advanced tumors especially de-differentiated liposarcoma and uterine leiomyosarcoma remains unsatisfactory, albeit intensive treatment regimens including …
-
Adaptive Biology, Driven by Metabolic Reprogramming, in Soft Tissue Sarcoma
Soft tissue sarcomas (STS) are mesenchymal tumors. Undifferentiated pleomorphic sarcoma (UPS), myxofibrosarcoma (MFS), and leiomyosarcoma (LMS) are common types of adult STS, while rhabdomyosarcoma (RMS) is a common pediatric STS. Treatment is multimodal, yet survival rates have remained largely …
-
Learning to Predict Clinical Outcomes from Soft Tissue Sarcoma MRI
Soft Tissue Sarcomas (STS) are among the most dangerous diseases, with a 50% mortality rate in the USA in 2016. Heterogeneous responses to the treatments of the same sub-type of STS as well as intra-tumor heterogeneity make the study of biopsies imprecise. Radiologists make efforts to find …
-
Proliferation and Survival Mechanisms in Soft Tissue Sarcoma and Glioblastoma Tumors
Soft tissue sarcomas and glioblastomas are two deadly tumors that are characterized by aggressive overproliferation, and regions of severe intratumoral nutrient and oxygen deprivation. The mechanisms by which tumors evade proliferation control signals and survive in a hostile microenvironment are …
-
Targeting Histone Deacetylases (Hdac) For The Treatment of Soft Tissue Sarcoma
… (HDAC) for the treatment of genetically complex soft tissue sarcoma Histone deactylase inhibitors (HDACi) are a new class of anticancer therapeutics; however, little is known about HDACi or the individual contribution of HDAC isoform activity in soft tissue sarcoma (STS). We investigated the …
-
Megavoltage radiation and electrons in the treatment of canine soft-tissue sarcoma
Soft-tissue sarcomas are a group of tumors that exhibit similar clinical behavior, namely, local invasiveness, a low metastatic rate, and frequent return following conservative excision. Histotypes such as fibrosarcoma (FSA), hemangiopericytoma (HPC), malignant fibrous histiocytoma, and malignant …
-
Dissecting the Role of ATRX in Soft Tissue Sarcoma Development and Therapeutic Response
… is one of the most frequently altered genes in soft tissue sarcoma, with alterations occurring in 29% of these tumors. However, the role of ATRX in the development and response to cancer therapies in soft tissue sarcoma remains poorly understood. Here, we developed a primary mouse model of soft …
-
Tumour associated macrophages in soft tissue sarcoma: recruitment, immune suppression, and therapeutic response
Soft tissue sarcomas (STS) are mesenchymal lineage malignant neoplasms with a high rate of fatality. Treatment is limited to neoadjuvant radiation therapy (RT) and surgery, which has not changed in decades. Novel immunotherapies have generally been unsuccessful in STS, which is due to an immune …
-
Investigating Interactions Between Hypofractionated Radiation and STING Agonism in Murine Soft Tissue Sarcoma
Undifferentiated pleomorphic sarcoma (UPS) is an aggressive, high-fatality soft tissue sarcoma with limited systemic treatment options. It is among the more immune-responsive sarcoma subtypes, yet most patients derive no durable benefit from immune checkpoint inhibition. The intratumoural STING …
-
RNA-sequencing-based risk stratification and individualized immunotherapy strategies for soft tissue sarcoma
… and individualized immunotherapy strategies for soft tissue sarcoma'.
-
An Electrochemical Immunoassay System for Measuring Circulating Protein Biomarkers of Pediatric Soft Tissue Sarcoma
… and osteopontin (OPN)) associated with pediatric soft tissue sarcomas (PSTS). Magnetic bead bioconjugates are functionalized with large amounts of antibody and enzyme labels, electrode arrays are modified with gold nanoparticles and antibodies for specific capture of bioconjugate-labeled …
Page 1 of 8